ENDING THE OPIOID CRISIS

BY THE NUMBERS

81

THOUSAND

There are over 81,000 opioid overdose deaths in the United States last year, according to the CDC. That's an average of 221 opioid overdose deaths per day.

Source: CDC

10

MILLION

Over 10 million Americans misuse prescription opioids each year, according to the most recent data from the HHS.

Source: HHS

79

BILLION

The CDC estimates that the economic impact of the opioid crisis is $79 Billion in lost productivity, medical, and rehabilitation services,

Source: CDC

MEET RUNATEK

OUR STORY

We started out as college friends looking for a purpose in our lives and a way to make a difference in the world around us. We were touched by lives torn apart from drug addiction and the massive opioid epidemic ravaging our country, and we knew that we had to do something about it. So, we founded Runatek to develop a medical device that can prevent opioid addictions in the first place. Our purpose is to save lives with this ground-breaking technology.

OUR VISION

Our mission is simple: End the Opioid Crisis.

TECHNOLOGY

We're developing a wearable IV pump that monitors the concentrations of prescription opioid medication in the bloodstream. The device uses a measurement of the patient’s body mass and the doctor’s prescription to set a proper blood concentration level for the patient to achieve pain relief without experiencing a potentially addicting “high.” The device automatically administers intravenous (IV) opioid medications to maintain this prescribed concentration without the possibility of misuse. 

 

INTRODUCING THE SOTIRAS

 

INVEST IN THE FUTURE OF MEDICINE

We are seeking keen investors to join our team and help take us to the next level. We will be launching a VC round in 2021 to raise capital to get our technology through the FDA approvals process. 

As with any investment, there is a certain degree of risk. We do everything that we can to protect and grow the investment through smart management practices. We strive to be open and transparent about the operations and direction of our organization, so that investors can make confident investment decisions. Our investors receive regular updates on the performance of the company and are a key part of our decision process during annual meetings.

 

For more information, download our annual report here or contact us here.

 
 

OUR TEAM

We're an early-stage startup, and we're attracting top-notch talent to our growing team of over a dozen dedicated individuals. Our team members come from a variety of backgrounds, but we all share the same goal: to end the opioid crisis.

Matthew Lucci
Chief Executive Officer
          Mr. Lucci leads the company's business and product development. He brings three years of entrepreneurship experience as president of a small marketing firm, and a year of C-Suite experience to the Runatek team. He has been developing medical devices for three years and has published his research in multiple academic journals.
          He is a Mechanical Engineering alum of Southern Methodist University and holds a master's degree in Mechanical Engineering from the University of Texas at Tyler, and has since studied drug development and approval at Harvard Medical School.
Summer College
Internship Program
         Runatek's internship program is a great hands-on learning opportunity for students in STEM and Business majors. Engineering interns work alongside senior members of the Runatek team to develop medical hardware and software, while Business interns work with senior members of the team in startup finance, marketing, communications, and more. 
         Our Summer 2021 cohort boasts students from SMU, UT Tyler, LSU, Johns Hopkins, TCU, and more. We'll currently hiring interns for Fall 2021 very soon. Interested applicants can  find more information here.

CONTACT US

Sign up for updates and add your name to our list of people committed to ending the opioid crisis.

Thanks for submitting!